Folgen
Stephanie Harvard
Stephanie Harvard
University of British Columbia
Bestätigte E-Mail-Adresse bei ubc.ca
Titel
Zitiert von
Zitiert von
Jahr
HIV/AIDS in Vancouver, British Columbia: a growing epidemic
CW McInnes, E Druyts, SS Harvard, M Gilbert, MW Tyndall, VD Lima, ...
Harm Reduction Journal 6, 1-5, 2009
712009
Agreement between aggregate and individual-level measures of income and education: a comparison across three patient groups
CA Marra, LD Lynd, SS Harvard, M Grubisic
BMC health services research 11, 1-7, 2011
492011
Consumer preferences for food allergen labeling
CA Marra, S Harvard, M Grubisic, J Galo, A Clarke, S Elliott, LD Lynd
Allergy, Asthma & Clinical Immunology 13, 1-11, 2017
382017
Social, ethical, and other value judgments in health economics modelling
S Harvard, GR Werker, DS Silva
Social Science & Medicine 253, 112975, 2020
362020
Genotype D amongst injection drug users with acute hepatitis B virus infection in British Columbia
C Panessa, WD Hill, E Giles, A Yu, S Harvard, G Butt, A Andonov, ...
Journal of Viral Hepatitis 16 (1), 64-73, 2009
332009
Randomized controlled trial evaluating pictogram augmentation of HIV medication information
K Wilby, CA Marra, JH da Silva, M Grubisic, S Harvard, LD Lynd
Annals of Pharmacotherapy 45 (11), 1378-1383, 2011
312011
Evolution of direct costs in the first years of rheumatoid arthritis: impact of early versus late biologic initiation-an economic analysis based on the ESPOIR cohort
K Chevreul, G Haour, S Lucier, S Harvard, ML Laroche, X Mariette, ...
PLoS One 9 (5), e97077, 2014
282014
Mortality is influenced by locality in a major HIV/AIDS epidemic
EF Druyts, BS Rachlis, VD Lima, SS Harvard, W Zhang, EK Brandson, ...
HIV medicine 10 (5), 274-281, 2009
232009
Value judgments in a COVID-19 vaccination model: a case study in the need for public involvement in health-oriented modelling
S Harvard, E Winsberg, J Symons, A Adibi
Social Science & Medicine 286, 114323, 2021
222021
Costs of early spondyloarthritis: estimates from the first 3 years of the DESIR cohort
S Harvard, D Guh, N Bansback, P Richette, M Dougados, A Anis, ...
RMD open 2 (1), e000230, 2016
202016
Ontario’s plunging price-caps on generics: deeper dives may drown some drugs
A Anis, S Harvard, C Marra
Open Medicine 5 (3), e149, 2011
202011
The epistemic risk in representation
S Harvard, E Winsberg
Kennedy Institute of Ethics Journal 32 (1), 1-31, 2022
172022
Purposes and duties in scientific modelling
E Winsberg, S Harvard
J Epidemiol Community Health 76 (5), 512-517, 2022
162022
More than just needles: An evidence-informed approach to enhancing harm reduction supply distribution in British Columbia
JA Buxton, EC Preston, S Mak, S Harvard, J Barley, ...
Harm Reduction Journal 5, 1-7, 2008
142008
Health economists on involving patients in modeling: potential benefits, harms, and variables of interest
S Harvard, GR Werker
Pharmacoeconomics 39, 823-833, 2021
122021
Harm reduction product distribution in British Columbia
SS Harvard, WD Hill, JA Buxton
Canadian journal of public health 99, 446-450, 2008
122008
Canadian policy on food allergen labelling: consumers’ perspectives regarding unment needs
KM Brown, NE Fenton, LD Lynd, CA Marra, JM FitzGerald, SS Harvard, ...
Univers J Public Health 3, 41-48, 2015
112015
Measurable definitions of ankylosing spondylitis management recommendations are needed for use in observational studies
S Harvard, L Gossec, T Pham, P Richette, M Dougados, A Anis, B Fautrel
Joint bone spine 83 (1), 101-103, 2016
92016
Causal inference, moral intuition, and modeling in a pandemic
S Harvard, E Winsberg
Philosophy of Medicine 2 (2), 2021
82021
Programmable interface for statistical & simulation models (prism): Towards greater accessibility of clinical and healthcare decision models
A Adibi, S Harvard, M Sadatsafavi
arXiv preprint arXiv:2202.08358, 2022
72022
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20